Issue 85, 2018

LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance

Abstract

The chemical compound LY2874455 has the potential to overcome drug resistance driven by FGFR gatekeeper mutations. X-ray crystallographic studies provide the structural explanation for why this compound is effective against the FGFR gatekeeper mutations.

Graphical abstract: LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance

Supplementary files

Article information

Article type
Communication
Submitted
18 Sep 2018
Accepted
28 Sep 2018
First published
29 Sep 2018

Chem. Commun., 2018,54, 12089-12092

LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance

D. Wu, M. Guo, X. Min, S. Dai, M. Li, S. Tan, G. Li, X. Chen, Y. Ma, J. Li, L. Jiang, L. Qu, Z. Zhou, Z. Chen, L. Chen, G. Xu and Y. Chen, Chem. Commun., 2018, 54, 12089 DOI: 10.1039/C8CC07546H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements